Trial intelligence / Profile preview

Ropivacaine LIA for Postoperative Pain in Hip Hemiarthroplasty

NCT02585011Completed

Sponsor
St. Olavs University Hospital
Start
Dec 2015
Primary completion
May 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial in postoperative pain comparing Ropivacaine with Placebo (2 arms). Primary endpoint: Pain sensation during mobilization in the post-anesthesia care unit at 24 hours. Started Dec 2015; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02585011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02585011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call